Font Size

SCREEN

Profile

Direction

Menu Style

Options X Conference

In Brief
  1. ISIRV Journal: Another year-on-year increase - IRV impact factor now 2.954
  2. Abstract Submission for OPTIONS X Conference is now closed - Late Breaker submission 1-15 July

MEMBERSHIP BENEFITS...

  • Discounted isirv conference rates
  • Opportunities to network and connect with world experts in the field of respiratory virus diseases
Member Login

CONTACT



OPTIONS X - Singapore
28 August - 1 September 2019

Welcome to the 10th edition of the Options for the Control of Influenza conference in Singapore. This is ISIRV's premier event and remains the largest international conference exclusively dedicated to influenza prevention, control and treatment, including seasonal flu and pandemic preparedness. Highlights of the meeting include: new tracks on influenza co-infections with other viral pathogens and key issues for policy making - a special session to showcase the latest developments in Chinese-speaking countries - pre-conference workshops on a wide variety of topics including technology, mathematical modelling and bioinformatics. Submission for late breaking abstracts 1-15 July.   

Visit the OPTIONS X website

 

Pre-Conference events:
27 August        High-Level Isolation and Outbreak Management
28 August        Special Session - Latest research from China
28 August        Health Technology Assessment for Vaccines Workshop
28 August        School of Influenza - Intensive Preparation Session​

Register here  

SAVE THE DATE 12th International RSV Symposium
9 - 12 September 2020

RSV2020 is currently in the planning stage and this time will be hosted in Belfast, Northern Ireland. It follows on the success of RSV2018, and will deliver an equally impressive programme of similar format. Watch this space...

SCIENCE NEWS
 
Global Influenza Update

An update based on data up to 6 January 2019 can be found here.

Influenza Vaccine

The recommended composition of influenza virus vaccines for use in the 2019 southern hemisphere influenza season can be found here.

Zoonotic Influenza

Antigenic and genetic characteristics of zoonotic influenza viruses and candidate vaccine viruses developed for potential use in human vaccines' is here.

MERS-CoV

Information and links to other sources of information on this evolving situation is available in the news section.

SOCIETY NEWS
 
6th AVG Conference: Advances in Respiratory Virus Therapeutics | Washington DC, USA 13-15 November 2018

This conference addressed both pre-clinical and clinical advances in therapeutic and prophylactic agents for influenza, RSV and other respiratory viruses and regulatory issues central to advancing such agents to clinical practice. A report has been published in Antiviral Research with free access till 4th June.Read more

New Special Interest Group is announced - International Respiratory Syncytial Virus Society

In mid-2017, the International Respiratory Syncytial Virus Society (IRSVS) became a special interest group of isirv. The IRSVS is a global independent group of RSV professionals, with members from all continents working on all research fronts. The IRSVS’s goal is to ensure that there is a succession of venues to share scientific information and accelerate the development of strategies to reduce the impact of RSV infection. Read more...


Highlights from Influenza 2018: Centenary of the 1918 Pandemic | 24-26 June at the Crick Institute, London

The greatest public health disaster in recorded history, the Spanish Flu, began in springtime of 1918 and developed within a few months into a global pandemic with an estimated 50-100 million deaths. By its end, the pandemic had caused a reduction of life expectancy in the US by 12 years, and killed more people than died in the First World War. Read more...

RECENT MEETINGS
 
Immunological Assays and Correlates of Protection for Next Generation Influenza Vaccines: 31 March - 2 April 2019, Siena, Italy

This conference addressed new immunological assays and immune correlates of protection needed to estimate the immunogenicity and protective efficacy of next generation influenza vaccines currently being developed.Visit the website  

 
2nd Epidemiology meeting: Incidence, Severity and Impact of Influenza 16-18 January 2019, Stockholm

Final Programme here.


The ISIRV Journal, Influenza and other Respiratory Viruses, is now published in an online only format. No printed issue will be produced but authors will still be able to order offprints of their own articles. ISIRV members will receive a 10% discount for articles submitted.

Contact membership@isirv.org for the code.